2026 жылында Таиландта созылмалы обструктивті өкпе ауруын (соөа) діңгекті жасушалармен емдеуге бойынша ең жақсы бағалар мен клиникалар туралы біліңіз

Stem cell therapy for COPD in Thailand is safe in regulated facilities. This follows a 2026 ministerial decree classifying therapies as registered medicines. While clinics report better lung function, it remains an experimental treatment rather than a standard cure.

• Regulatory status: New 2026 laws classify mesenchymal stem cells (MSCs) as specialised medicinal products.
• Safety standards: Registered clinics must follow strict production, safety, and evidence-based protocols.
• Treatment efficacy: Research focuses on reducing inflammation rather than reversing established lung damage.
• Procedure costs: Local treatment typically ranges from $12,000 to $22,000 for 100 million cells.

Bookimed Expert Insight: Thailand is a global hub with 150+ clinics. Only facilities like ID Clinic Bangkok maintain active Australian patient pathways. These clinics treat 4,000+ patients annually. Patients should choose clinics using mesenchymal cells with only 3–4 culture passages. This preserves the potency needed for respiratory conditions.

Patient Consensus: Many patients find these treatments more accessible than domestic options. However, they still view them as experimental. People often check cell source and count carefully to manage expectations for this therapy.

Specialised clinics in Bangkok and Phuket treat Chronic Obstructive Pulmonary Disease (COPD). They use mesenchymal stem cells (MSCs) to reduce lung inflammation. These therapies involve high-cell-count infusions, typically from 50 million to 100 million cells. They aim to improve breathing and reduce chronic coughing.

• Treatment focus: Clinics use mesenchymal stem cells (MSCs) to target damage from chronic bronchitis.
• Facility types: Most procedures occur in Bangkok units like ID Clinic Bangkok or Phuket.
• Regulatory status: Therapies are offered as regenerative treatments rather than traditional curative clinical trials.
• Inclusions: Packages usually cover pulmonary diagnostics, cell infusions, accommodation, and airport transfers.
• Cost range: Treatment typically costs from $12,000 to $22,000 in Thailand.

Bookimed Expert Insight: Thailand hosts over 150 clinics offering stem cell services. High-volume centres in Bangkok serve 4,000+ international patients annually. While some clinics use stem cells for aesthetic procedures, others provide 10-day intensive protocols. These protocols focus on lung regeneration and immune modulation.

Patient Consensus: Patients find Thailand geographically convenient. However, they emphasise the importance of checking cell manufacturing and laboratory testing transparency. Many report reduced coughing and improved energy levels after finishing their infusion protocols.

Stem cell treatment for COPD in Thailand aims to reduce lung inflammation and improve breathing using mesenchymal stem cells (MSCs). Most patients report better quality of life and increased stamina. They also see higher oxygen saturation levels rather than a complete cure.

• Respiratory function: Patients often see reduced airway inflammation and easier breathing.
• Physical stamina: Improved energy levels allow for more consistent daily activity.
• Oxygen saturation: Increased blood oxygen levels can reduce the need for supplemental oxygen.
• Symptom reduction: Many experience less chronic coughing and lower mucus production.
• Clinical benchmarks: Specialist clinics use spirometry and 6-minute walk tests to measure progress.

Bookimed Expert Insight: Thailand is a global hub with 150+ clinics, but results depend on the disease stage. Data from clinics like ID Clinic Bangkok show the most consistent outcomes. This clinic treats 4,000+ patients annually, mostly those with moderate lung capacity.

Patient Consensus: Expect small but meaningful gains, such as walking further without gasping. Results vary between patients. Focus on functional improvements rather than expecting a total reversal.

Stem cell therapy for COPD introduces mesenchymal stem cells (MSCs) into the bloodstream. These cells help reduce airway inflammation and promote tissue repair. They migrate to damaged lung areas to slow disease progression and improve respiratory function. Clinics in Thailand typically use intravenous infusions to deliver cells safely.

• Immune modulation: Stem cells release anti-inflammatory factors to calm chronic airway and lung irritation.
• Tissue repair: Therapy aims to stimulate regeneration of damaged alveoli and basal lung cells.
• Vascular support: New capillary formation may improve oxygen transfer and stamina for daily activities.
• Delivery method: Practitioners usually administer cells via intravenous (IV) drip for systemic circulation.

Bookimed Expert Insight: Thailand is a major hub for regenerative medicine, with 154 clinics offering these therapies. Many patients seek treatment for emphysema. However, the most consistent results appear in those seeking an intensive anti-inflammatory boost. Success often depends on cell culture quality rather than just the total cell count.

Patient Consensus: Patients in Thailand often report improved energy and easier breathing shortly after the infusion. This approach works best to manage symptoms and slow progression rather than providing a permanent cure.

Mesenchymal Stem Cells (MSCs) are the most effective type for treating COPD. They target lung inflammation and are typically harvested from a patient's own fat tissue or bone marrow. This helps repair damaged air sacs and improves breathing capacity.

• Mesenchymal Stem Cells: MSCs from fat or bone marrow reduce chronic inflammation and help lung regeneration.
• Adipose-derived cells: Surgeons harvest these from fat tissue to target systemic inflammation and improve mobility.
• Bone marrow cells: This approach uses endothelial progenitor cells to repair damaged air sacs naturally.
• Stem cell secretome: This cell-free inhalation or IV treatment uses therapeutic factors to target lung tissue.

Bookimed Expert Insight: Thailand is a global hub for regenerative medicine with over 150 specialised clinics. Many Australian patients seek treatment for lung conditions there. Data shows Thailand serves over 2,000 international cases annually. It ranks third globally for these specialised respiratory requests.

Patient Consensus: Patients in Thailand often report improved breathing and better exercise tolerance. Many highlight the importance of choosing clinics that provide clear details on cell sourcing and testing.

The medical process for COPD stem cell treatment in Thailand takes 5–10 days in Bangkok. It involves remote record review and onsite lung function testing. Specialists use intravenous infusion of mesenchymal stem cells. They typically use umbilical cord-derived cells or adipose tissue to help repair lung structure. Doctors harvest this tissue via mini-liposuction.

• Clinical assessment: Specialists perform CT scans and lung function tests upon arrival.
• Cell harvesting: Doctors may use mini-liposuction to collect fat-derived stem cells.
• Laboratory processing: Harvested cells undergo concentration or cultivation in specialised facilities.
• Intravenous infusion: Concentrated stem cells enter the bloodstream via a standard IV drip.
• Supportive care: Programs often include pulmonary consultations and intensive follow-up monitoring.

Bookimed Expert Insight: Thailand has 154 clinics offering these therapies. Bangkok serves as the primary hub. Data shows high-dose protocols using 80–100 million cells often cost 40–50% more than standard infusions. Checking the passage number—how many times cells were cultured—helps confirm product quality before treatment begins.

Patient Consensus: Patients follow a direct-to-clinic pathway involving remote enquiries and onsite screenings in Thailand. Experience shows it is vital to confirm whether clinics use mesenchymal cells or exosomes for respiratory support.